BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9738847)

  • 1. Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus.
    Barg N
    J Antimicrob Chemother; 1998 Aug; 42(2):257-60. PubMed ID: 9738847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Managing children skin and soft tissue infections].
    Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibacterial activity of a new 3-azinomethyl-rifamycin.
    Strippoli V; Bruzzese T; Galli R; Simonetti N; Tronci N
    Farmaco Sci; 1988; 43(7-8):619-25. PubMed ID: 3147199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
    Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
    Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of bacterial resistance to macrolides.
    Halpern MT; Schmier JK; Snyder LM; Asche C; Sarocco PW; Lavin B; Nieman R; Mandell LA
    J Antimicrob Chemother; 2005 May; 55(5):748-57. PubMed ID: 15772147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells.
    Krut O; Sommer H; Krönke M
    J Antimicrob Chemother; 2004 Feb; 53(2):167-73. PubMed ID: 14729736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of azithromycin in ORL].
    Gehanno P
    Pathol Biol (Paris); 1995 Jun; 43(6):530-3. PubMed ID: 8539077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
    Gill CJ; Abruzzo GK; Flattery AM; Smith JG; Jackson J; Kong L; Wilkening R; Shankaran K; Kropp H; Bartizal K
    J Antibiot (Tokyo); 1995 Oct; 48(10):1141-7. PubMed ID: 7490222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
    Noviello S; Ianniello F; Leone S; Esposito S
    J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
    Senses Z; Baysallar M; Gür D; Doğanci L
    Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.
    Girard D; Finegan SM; Dunne MW; Lame ME
    J Antimicrob Chemother; 2005 Aug; 56(2):365-71. PubMed ID: 16002421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
    Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study.
    Godin B; Touitou E; Rubinstein E; Athamna A; Athamna M
    J Antimicrob Chemother; 2005 Jun; 55(6):989-94. PubMed ID: 15857943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic effect of some antibiotics on experimental staphylococcal infection and its correlation with in vitro activity of antibiotics in sub-inhibitory concentration against Staphylococcus aureus strains].
    Kaczmarska L; Jakoniuk P
    Med Dosw Mikrobiol; 2003; 55(1):1-10. PubMed ID: 12908409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications.
    Kaplan EL; Chhatwal GS; Rohde M
    Clin Infect Dis; 2006 Dec; 43(11):1398-406. PubMed ID: 17083011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of benefit of intravenous immune globulin in a murine model of group A streptococcal necrotizing fasciitis.
    Patel R; Rouse MS; Florez MV; Piper KE; Cockerill FR; Wilson WR; Steckelberg JM
    J Infect Dis; 2000 Jan; 181(1):230-4. PubMed ID: 10608771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of antibiotic resistance of Staphylococcus aureus in general practice.
    Manners BT; Grob PR; Beynon GP; Gibbs FJ
    Practitioner; 1976 Apr; 216(1294):439-42. PubMed ID: 1046672
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of dosing intervals on efficacy of clarithromycin and erythromycin in mouse infection models.
    Fernandes PB; Swanson RN; Hardy DJ; McDonald EJ; Ramer N
    Drugs Exp Clin Res; 1988; 14(7):441-4. PubMed ID: 2977115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia].
    Veber B; Pocidalo JJ
    Pathol Biol (Paris); 1995 Jun; 43(6):524-8. PubMed ID: 8539075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.
    Dorfman MS; Wagner RS; Jamison T; Bell B; Stroman DW
    Adv Ther; 2008 Mar; 25(3):208-17. PubMed ID: 18369536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.